This trial is testing how well radiation therapy and chemotherapy work together to treat rectal cancer.
- Rectal Cancer
- Stage IIA Rectal Cancer
- Stage II Rectal Cancer
- Stage IIIB Rectal Cancer
- Stage IIB Rectal Cancer
- Stage IIIC Rectal Cancer
- Stage III Rectal Cancer
- Stage IIIA Rectal Cancer
1 Primary · 7 Secondary · Reporting Duration: Up to 5 years
Awards & Highlights
1 Treatment Group
Treatment (IMRT, mFOLFOX6, CapeOX, TME)
1 of 1
25 Total Participants · 1 Treatment Group
Primary Treatment: Intensity-Modulated Radiation Therapy · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
In which conditions is Intensity-Modulated Radiation Therapy usually applied?
"Intensity-Modulated Radiation Therapy is customarily employed in rectal carcinoma treatment, but can also be utilized to treat metastatic colorectal carcinoma, pancreatic endocrine carcinoma, and advanced esophageal cancers." - Anonymous Online Contributor
What potential risks can be associated with Intensity-Modulated Radiation Therapy?
"As this is an early-stage Phase 1 trial, our team at Power assigned Intensity-Modulated Radiation Therapy a score of 1 on the safety scale—lowest because there is limited evidence for its efficacy and safety." - Anonymous Online Contributor
What is the scope of participants in this investigation?
"Affirmative. Per the information available on clinicaltrials.gov, this medical study is actively recruiting participants with its initial post date of February 11th 2021 and latest update occurring on January 13th 2022. The trial requires 25 patients from 1 site to complete enrollment." - Anonymous Online Contributor
Has Intensity-Modulated Radiation Therapy undergone any other clinical testing prior to this?
"Currently, 726 trials are taking place to investigate the efficacy of Intensity-Modulated Radiation Therapy. Of these studies, 249 have reached Phase 3. In regards to location, while the majority of clinical research is being conducted in Guangzhou, Guangdong province, 29794 sites worldwide are running IMRT based experiments." - Anonymous Online Contributor
Are there any opportunities to join this experiment at present?
"Affirmative. The clinical trials website lists that this experiment is recruiting as of now - it was initially posted on February 11th 2021 and updated most recently on January 13rd 2022. 25 individuals are needed for the study at one medical facility." - Anonymous Online Contributor